Hubert Birner

Hubert Birner is a declared insider at 3 companies; the most frequent names are Argos Therapeutics Inc, Horizon Therapeutics Public Ltd Co and Protara Therapeutics, Inc. Over a trading history stretching from 2 August 2011 to 31 December 2016, the count stands at 25 filings.

On the market, this insider has only ever bought: 7 purchases, €3.6M in total. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants.

A typical purchase (the median) is worth €604k.

Most recently, on 4 January 2017, the filings show a share grant in Argos Therapeutics Inc. The last insider purchase was made public on 1 July 2016, 3,783 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.